The Seat Got Harder to Reach - Your Roadmap and Your Board Bi ...

By RaeAnn, Founder and Chief Executive Officer, HLTHWORKS

A first board seat is harder to reach now than it has been in years. Here is what changed, and here is what to do about it.

In 2025, Fortune 500 companies filled 383 board seats. Only about half of those companies appointed anyone at all. Of the seats that were filled, 74 percent went to people who had already served on a public company board. That is the second highest share since this was first tracked in 2011.

So the qualification for a first board seat has become a prior board seat. That is a closed loop, and it explains why strong candidates keep hearing nothing back. It is not a verdict on your record. It is a selection process tuned to reduce risk, and an unknown first time director is the risk it is tuned to avoid.

The loop has one opening

Boards are now being asked to oversee artificial intelligence, and most of them cannot do it with the directors they have. More than half of hospital board members, 56 percent, come from finance or business. About one in seven is a health professional. David Burik of The Governance Institute said it plainly. “You’re not going to get 15 AI experts on your board. You might not get one.”

Read that as an invitation rather than a complaint. A board that knows it cannot answer a question is a board willing to look outside its own circle for someone who can. That is the reliable way through a closed loop.

A nominating committee is not asking whether you are impressive. Impressive is common.

It is asking what gap you fill.

So the work is not to become more qualified in general. It is to become the obvious answer to one question a particular board is already worried about. Two things make that happen. A roadmap, and a bio that reads like a director.

Where the first seat usually is

Most people picture a public company board. Almost nobody starts there.

The first seat is usually a nonprofit board, a private or sponsor backed company board, or a formal advisory board. All three are real governance experience. All three put you in a room where strategy, risk, and executive performance are discussed. All three give you something to write down that a public company nominating committee will recognize.

Choose the one that matches where you want to end up. A nonprofit health system board builds credibility for health system work. A sponsor backed company board builds credibility for growth and transaction work. An advisory seat in a sector you want to govern builds the relationships that produce the next call. Treat the first seat as the start of a sequence rather than the destination.

The roadmap

Six steps. The first three are preparation. The last three are access.

ONE. ANSWER THREE QUESTIONS

Where do you want to serve? Profit or nonprofit, and in what sector. Why do you want it? Answer in one sentence you would say out loud to a nominating chair. What is your value? Name what you bring that the board cannot get from the directors it already has. Most people answer the first two and stall on the third.

TWO. NAME THE GAP

Pick four to six boards you would actually serve on. For each one, write down what it is missing. AI and data governance. Cybersecurity. Payer contracting. Risk adjustment. Clinical quality. Growth through an ownership change. Then present yourself as the answer to that gap, not as a summary of your career.

THREE. WRITE THE BOARD BIO NOW

Write it before anyone asks for it. The structure is on the next page. The version written in a hurry after a call comes in is the version that reads like a resume.

FOUR. FIX YOUR OWN THIN SPOTS

Read your list of qualifications and find what is missing. That is where your development plan starts. Financial literacy for an audit committee. Formal governance training. A first nonprofit or advisory seat. A published point of view on the subject you want to be called about.

FIVE. MAP WHO HAS ACCESS

For each target board, list the current directors, the executive team, the auditors, the lawyers, the consultants, the major vendors, and the recruiters who work that sector. Your professional network and the network that builds board short lists are usually two different groups of people.

SIX. START TALKING BEFORE THERE IS AN OPENING

A seat is filled from about two dozen names, a handful of calls, and two or three finalists. By the time an opening is public, that list already exists. The work that matters happens before anyone calls you.

Your board bio is not your resume

A resume answers what jobs you held. A board bio answers where you have sat at a board table and what you did there.

There are three ways to have sat at that table. Most executives count only the first.

DIRECTOR

You held a fiduciary or advisory seat. You voted. You served on committees.

ADVISOR

You served on an advisory board, a clinical advisory panel, or a governance committee, without a fiduciary vote.

BOARD CONTRIBUTOR

You reported to a board as an executive. The Chief Growth Officer who presented quarterly on pipeline and performance. The Chief Compliance Officer who owned the audit committee report. That is board table experience, and almost nobody writes it down.

Here is the same career written both ways.

RESUME LINE	BOARD BIO LINE
Led sales and marketing.	Reported quarterly to the board on growth strategy, pipeline, and commercial performance through an ownership transition.

The second line is not inflated. It is the same work described at the level a board cares about. What you were accountable for, who you answered to, and what was at stake while you did it.

The page, in order.

A positioning line. Two sentences. Who you are, and the gap you fill.
Board and governance experience, most recent first, using the three seats above.
Operating experience. Scope, scale, financial responsibility, and who you reported to.
Sector credentials. Only the two or three that make you the answer.
Education, certifications, and a current professional photograph.

Leave out early career roles, minor titles, and dates that do nothing but age you.

Then tailor it. One version per board, with the positioning line rewritten to the gap you named in step two. A general bio is read as a general candidate.

Before you say yes

It is an honor to be asked. That is not a reason to accept.

Ask what you would ask in diligence on anything else. Is the organization financially stable, and does the board discuss that openly? Is the mission one you can defend in public? Does the governance process work, or does one investor or one family settle everything before the meeting? Does every person on the board think the same way? Is there director and officer liability coverage, and have you read it?

Ask about time as well. Committee work, pre reads, and the calls between meetings are where governance actually happens, and none of it is described accurately when a seat is first offered. Find out how many meetings there are, which committee you would join, and how much material arrives before each one.

A weak board is a reputational risk that follows you into the next conversation. The seat you decline is often what makes the right seat possible.

The close

None of this gets easier on its own. Turnover is low, experience is being rewarded over potential, and the first seat is still the hardest one to reach.

What has changed is that boards now face questions, AI oversight above all, that their current directors cannot answer. That is a real opening. It is narrow, and it will not be filled by waiting.

Start with the three questions this week. Where, why, and what value. Write the bio while the answers are still fresh.

Traits get you considered. A pathway gets you chosen.

A closing observation

Healthcare organizations have spent three years asking who should own artificial intelligence and treating it as a question about org design. It is not. It is a question about continuity.

The executives currently holding these agendas are capable, and many of them are doing the work well. They will also move, retire, be recruited, or be reorganized, because that is what senior executives do and always have. An agenda that cannot survive that is not an agenda. It is a dependency.

The organizations that will be defensible in three years are not the ones that answered the ownership question most elegantly. They are the ones that wrote enough down that the answer stopped mattering so much.

Resources

The Board Bio Builder, a one page template you can complete and print, and the Breaking Into the Boardroom listener guide are on the HLTHWORKS resource page.

ALSO LISTEN

Redesigning Healthcare: Unfiltered, Episode 7. Breaking Into the Boardroom: How Healthcare Leaders Earn a Director Seat.

SOURCES

Heidrick and Struggles, Board Monitor US 2026, Fortune 500 board appointment data for 2025.
Ron Southwick, “Health systems should rethink board governance,” Chief Healthcare Executive, October 2026, reporting The Governance Institute and quoting David Burik.

HLTHWORKS builds artificial intelligence governance, scalability, sustainability, oversight, audit readiness, and a mature enterprise solution for medical groups, health systems, health plans, payers, and the vendors, plus investors serving them.